Immunize Your Patients Against Pertussis, Tetanus and Diphtheria

You play a vital role in protecting families against pertussis

Studies estimate that up to 3.3 million cases of pertussis occur each year among adults and adolescents.¹ Unfortunately, parents and other family members with pertussis can easily pass the disease to vulnerable infants.² By routinely immunizing adults and adolescents 11 through 64 years of age with Adacel vaccine, you help prevent the spread of pertussis to vulnerable infants.^3,5

For pediatricians

Help educate families by routinely discussing the need for Tdap^a vaccine with parents of vulnerable infants in your practice and encouraging them and other key contacts to be vaccinated.

For primary-care providers

Help build layers of protection against pertussis around vulnerable infants by routinely immunizing adults and adolescents 11 through 64 years of age with Adacel vaccine.

For you and your staff

Help reduce the risk of pertussis for you and those among your staff who have direct contact with patients through routine immunization with Adacel vaccine as is recommended by the ACIP³^,b

^a Tdap = Tetanus, diphtheria, and acellular pertussis.
^b ACIP = Advisory Committee on Immunization Practices.

Adults

Eligible adults 19 through 64 years of age should receive a single booster dose of Tdap vaccine to replace a single dose of Td vaccine for active booster immunization against tetanus, diphtheria, and pertussis.

Adolescents

The CDC recommends that eligible adolescents 11 through 18 years of age receive a single booster dose of Tdap vaccine, with a preferred age of 11 to 12 years.

Health-care professionals

Eligible health-care professionals who have direct contact with infants <12 months of age, as well as those in hospital or ambulatory-care settings, should receive a single booster dose of Tdap vaccine.

Infant caretakers

The CDC recommends that adults who have or who anticipate having close contact with an infant <12 months of age (eg, parents, grandparents <65 years of age, child-care providers, and health-care personnel) should receive a single booster dose of Tdap to reduce the risk of transmitting pertussis. An interval as short as 2 years from the last Td is suggested; shorter intervals can be used.

Pregnant women

When possible, eligible women should receive Tdap before becoming pregnant. Women who have not previously received Tdap should receive a dose of Tdap in the immediate postpartum period.